Sepsis, Septic Shock
8
2
2
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (8)
Fluids in Septic Shock (FISSH)
Multicenter Symphony™ IL-6 Monitoring Sepsis ED Pilot Study
Multicenter Symphony IL-6 Monitoring Sepsis ICU Validation Study
Role of Transposable Elements in Septic Immune Aging
Adjuvant Use of Neostigmine in Sepsis and Septic Shock.
Sodium Bicarbonate Ringer's Solution Versus Normal Saline for Early Fluid Resuscitation in Patients With Sepsis
Bedside vs. Standard Microbiological Blood Culture Diagnostics - BEMIDIA Study
IL 6 Measurement Using a New Densitometric Bedside (POC) Test